Latest Tables of Contents with Summaries

2019 Том 3, №2
A rare case of focal mid-ventricular form of Takotsubo syndrome
E.A. Vertinsky, L.Yu. Ushakova, M.V. Novikova
Stress cardiomyopathy, also called Takotsubo syndrome (TTS), broken heart syndrome and stress-induced cardiomyopathy, is characterized by transient regional systolic dysfunction of the left ventricle (LV) in the absence of angiographic evidence of obstructive coronary artery disease or acute plaque rupture as well as by regional wall motion abnormalities that extend beyond a single coronary vascular bed. TTS accounted for 1,7% to 2,2% of cases presenting with suspected acute coronary syndrome (ACS) or ST-elevation infarction in a systematic review. According to the International Takotsubo Registry, of 1750 patients with TTS, 89.8% were women (mean age 66,8 years). Complete recovery of LV systolic function is necessary to confirm the diagnosis of Takotsubo cardiomyopathy and can happen over a period of days to weeks. The typical and most common description of TTS is the apical type (81,7%), evident in the characteristic abnormality of a ballooned left ventricular apex with basal segmental hyperkinesis. However, atypical variants of this syndrome with mid-ventricular (14,6%), basal (2,2%) and focal (1,5%) wall motion patterns are increasingly diagnosed. We present a patient who developed a mid-ventricular dyskinetic TTS pattern.
Allergic purpura in the therapeutical practice
L. N. Romanchuk, V. M. Pyrochkin, Y. I. Karpovich, E. V. Chalaya, A. L. Belyaeva, Y. L. Karpovich, А.А. Shchetko
The article describes the clinical case of the Henoch-Schönlein disease in a patient of 53 years as an example of the relevance of the anamnestic data careful analysis, objective examination of the patient and the differential diagnosis for early detection. Polymorphism of cutaneous manifestations and visceral lesions can cause difficulties in the diagnosis of allergic purpura. Early administration of pathogenetically justified combined treatment leads to stabilization of the inflammatory process, avoidance of possible destruction of the internal organs as well as development of complications and relapses.
Nosocomial pneumonia: modern approaches to diagnosis and treatment
Zh.V. Antanovich
Nosocomial pneumonia (NP) is the second most common nosocomial infection and the main cause of death from nosocomial infections in critically ill patients. Most cases of NP are caused by aerobic gramnegative bacteria (P. aeruginosa, E. coli, K. pneumoniae, Acinetobacter spp.) and gram-positive cocci (S. aureus). From a practical point of view, in order to prescribe adequate initial antibacterial therapy (ABT) it is advisable to stratify patients depending on timing of the NP development and presence of risk factors (RF) for multidrug-resistant (MDR) pathogens. MDR pathogens are more often excreted in patients with severe chronic diseases and RF for the development of NP. Diagnostic criteria and Clinical Pulmonary Infection Score (CPIS) are used to diagnose NP and determine its severity. The outcome of treatment of patient with NP depends on the doctor’s level of knowledge and the most rapid administration of an adequate initial empiric ABT, presented in guidelines, taking into account local data on pathogens prevailing in the department and their resistance.
Chronic coronary syndromes: a review of the recommendations of the ESC-2019
A.S. Rudoy
The review summarizes the key points and main evidence of the updated modern recommendations of the European Society of Cardiology in 2019, which influenced the principles of management and treatment of patients with chronic coronary syndromes. The new concept and recognition of the importance of the multifactorial causes of angina pectoris and myocardial ischemia represents an important evolution in understanding the pathogenesis and treatment of coronary artery disease.
Personalized medicine and its role in type 2 diabetes prevention
V.V. Salukhov, B.V. Romashevskiy
Personalized medicine (PM) is a safe and effective way to prevent and treat type 2 diabetes mellitus (T2DM). The basic strategy of PM is to adapt various prevention and treatment methods to individual characteristics of patients, including their genome sequence, microbiome composition, life, case history and dietary preferences. The article highlights the prospects of personalized methods application for T2DM prevention based on the results of research in the field of genomics, metabolomics, intestinal microbiome technologies, pharmacogenetics and pharmacogenomics. The potential and advantages of mobile applications and technologies for large amounts of data assessment (“Big Data”) in the PM structure are demonstrated. The findings on the role of pharmacogenetics and pharmacogenomics in the selection of effective and safe drugs for T2DM treatment are presented. In conclusion, it was noted, that it would be feasible to conduct population –based studies confirming the effectiveness, profitability and advantages of PM compared to traditional T2DM prevention and treatment methods.
Association of HIF-1α genetic polymorphism with the risk of obstructive sleep apnea-hypopnea syndrome in atrial fibrillation patients with ischemic heart disease and/or arterial hypertension
T.I. Balabanovich, V.I. Shishko, T.L. Stepuro, V.R. Shulika
Aim: to explore the relationship between hypoxia inducible factor-1α (HIF-1α) (С1772T) gene polymorphism and the risk of obstructive sleep apnea-hypopnea syndrome (OSAHS) in atrial fibrillation (AF) patients with ischemic heart disease and/or arterial hypertension.
Wrapping of the dilated ascending aorta in patients with aortic valve pathology
D.А. Bozhko, Y.М. Chesnov, S.V. Spiridonov, S.А. Kurganovich
The method for ascending aorta wrapping developed at the “Cardiology” Republican Scientific and Practical Centre, Belarus, has been used in the treatment of 93 patients. The analysis of early and long-term treatment results was performed. A short time of ischemia and cardiopulmonary bypass, a low level of postoperative complications, including repeated operations for bleeding (3.23%) were noted. According to echocardiography data, a significant decrease in the average diameter of the ascending aorta, from 45.33 ± 3.12 mm to 36.26 ± 4.09 mm, was marked. In the long-term follow-up period no significant changes in the size of the ascending aorta at all levels were observed; rapid aorta dilatation, aneurysm formation, dissection, aorta rupture, and such complications as uterus erosion, dislocation of the wrap and aortic kinking were also not revealed.
Specific features of lipid metabolism in children with cardiac risk factors
O.N. Volkova, V.D. Yushko, N.N. Bylinskiy, V.V. Strogiy
The article presents the data on the role of lipid metabolism disorders, including fatty acid metabolism disorders, among children with cardiac risk factors: arterial hypertension, obesity and aggravated atheroselrosis heredity.
The role of endothelial dysfunction and oxidative stress in the formation of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease
N.Yu. Grigoryeva, M.V. Mayorova, M.O. Samoluk, T.P. Ilyushina
The purpose of this study was to evaluate oxidative stress and endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) who had concomitant cardiovascular pathology.
The level of homocysteine and polymorphisms of genes of folate exchange in patients with coronary heart disease and diabetes mellitus type 2
E.V. Davydchyk, V.A. Snezhitskiy, T.L. Stepuro, E.M. Doroshenko, V.Yu. Smirnov
The aim of the study is to investigate the level of homocysteine (Hcy), distribution of frequencies of alleles and genotypes of polymorphic options С677Т, А1298С of gene MTHFR, A66G of gene MTRR, А2756G of gene MTR in patients with chronic coronary heart disease (CHD) in combination with diabetes mellitus (DM) type 2.
Adipose tissue metabolic activity in chronic obstructive pulmonary disease patients in case of chronic nonspecific inflammation
D.V. Lapitski, A.N. Ryapolov, V.A. Pupkevich, T.V. Chirikova, I.B. Butyanovskaya, R.F. Ermolkevch, A.A. Arabey, A.V. Goncharik, G.A. Ibragimova, N.P. Mitkovskaya
The article addresses the dynamics of adipose tissue hormones leptin (LN) and adiponectin (AN) depending on nonspecific inflammation (NI) degree, as well as relations between adipokin and glucose/lipids metabolic disorders, adipose tissue capacity with different NI degrees in patients with chronic obstructive pulmonary disease (COPD). NI is associated with a high AN degree and a low LN degree which promotes the increase in metabolic substrata intake for immunity caloric supply. NI decrease is associated with a low AN degree and a highLN degree which promotes increase in adipose tissue capacity and worsening of glucose/lipids metabolic disorders. Nebivolol administration is associated with increase in AN level. Statins administration results in decrease in AN level and increase in LN level, due to reduced NI. Thus, treatment strategy in COPD patients should include some measures to prevent adipose tissue capacity increase and glucose/lipids metabolic disorders when NI is reduced.
Evaluation of health-related quality of life in patients with avascular necrosis
N.А. Martusevich, К.V. Gudkevich
Aim: to evaluate Health-Related Quality of Life (HRQL) in patients with avascular necrosis (AN) and to identify the most significant risk factors, which lead to low HRQL in patients with AN.
Results of factor analysis of laboratory resistance markers to acetylsalicylic acid in patients with stable angina
T.P. Pronko, V.A. Snezhitskiy, V.R. Shulika
The aim of the study was to assess the markers influencing the development of acetylsalicylic acid (ASA) laboratory resistance in patients with stable angina.
Non-sjögren syndrome dry eye in general medical practice: causes, outcomes, treatment tactics
G.R. Semak, V.A. Zaharava, S.K. Kletsky, T.A. Liatkovskaya, I.Yu. Zherko
Recently, non-Sjogren’s eye disease (DED) has become increasingly frequent in the therapeutic practice. In the Republic of Belarus, about 17–25% of the population over 40 years old suffer from corneal conjunctival xerosis of various severity. DED can develop both as an outcome of eye diseases and on the background of somatic pathology (diabetes mellitus, systemic atherosclerosis, menopausal syndrome, arterial hypertension, thyroid disease and metabolic syndrome) and is often associated with the systemic and topical use of medications (β-blockers, diuretics, analgesics, antidepressants, etc.). With the progression of corneal dystrophy and albugo formation, various types of donor cornea keratoplasty are used. In the best clinics, a 5-year transplant survival associated with the tear film deficiency is less than 50%.
Prevention of cardiovascular complications in the long-term period of initial percutaneous coronary intervention
N.L. Tsapaeva, S.F. Zolotuhina, E.V. Mironova, N.V. Tarashkevich, N.I. Egorova
The aim of present study investigate the clinical, instrumental and biochemical markers of the risk of cardiovascular complicated in long-term of initial percutaneous coronary intervention.
Radical correction of Fallot’s tetralogy in children after right ventricle outflow stenting
P.F. Charnahlaz, Y.I. Linnik, A.V. Bashkevich, E.V. Korolkova, A.I. Savchuk, N.S. Shevchenko, K.V. Drozdovski
The aim is to compare the results of radical correction of Fallot’s tetralogy in children after endovascular stenting of the outflow tract of the right ventricle and Blalock-Taussig shunt.
New technique for surgical left atrial appendage closure during mitral valve surgery
A.Р. Shket, E.Е. Stepanova, M.V. Zimina, T.V. Hlybouskaya, A.A. Komarovsky, O.I. Kozlov, S.I. Kozlov, Y.V. Vasilevich, V.A. Tokunov, D.I. Krachak, O.V. Lubimova, V.D. Krachak
The aim of work is to demonstrate the new surgical approach of left appendage closure from inside the left atrium during open heart surgery on mitral valve and early results of this method.
Possibilities of the volume sphygmography method in identification of atherosclerotic arterial damage markers in elderly and senile people
E.А. Siamushina, L.A. Zhilevich, L.M. Sychik
The article describes the potential of the method of volume sphygmography (VS) using the VaSera VS-1500N apparatus (Fukuda Denshi, Japan) in identifying a combination of markers of atherosclerotic arterial lesions in centenarians. For this purpose, we conducted a survey of 36 centenarians at the Republican Clinical Hospital for Disabled Veterans of the Great Patriotic war named after P. M. Masherov.
Psychometric analysis of the questionnaire «the quantification inventory for somatoform syndromes» (QUISS)
Т.Е. Tomashchyk
Somatoform disorders represent a group of psychiatric disorders manifested primarily in physical symptoms, which are clinically unexplained. Diagnosis of somatoform disorders requires taking into account not only the somatic symptoms and their severity, but also additional emotional, cognitive, behavioral and psychosocial aspects. The questionnaire “The quantification inventory for somatoform syndromes” (QUISS) meets the above-mentioned requirements. The questionnaire exists in the English version and requires standardization for the Belarusian population of patients, as well as compliance with current psychometrics.
Structural features of the valvular apparatus of the human heart in early embryogenesis
A.R. Rombalskaya
The article presents the data on the structural features of the development of atrioventricular valves (tendon chords, papillary muscles) in early embryogenesis and shows the development of fleshy trabeculae as structures from which papillary muscles are formed. The stages of development of these structures are described. It has been found that fleshy trabeculae in the form of a reticular plexus are the first to be visualized the first in the ventricles of the heart of embryos of 6 mm parietal-coccygeal length (TCD), and some of them, protruding into the ventricular cavity, form papillary muscles. As the size of the human embryo heart increases, the leaflets of atrioventricular valves and papillary muscles move away from each other and strands with a muscular component appear between them – future tendon chords (in embryos 18–19 mm TCD). Gradually, the muscle tissue in the tendon chords and atrioventricular valves is replaced by connective tissue and intraventricular formations approach the definitive structure (in embryos 65–70 TCD).
History of telemedicine in the Russian Federation
P.N. Shepel, A.V. Kutcher, T.V. Vakhovskaya, O.M. Drapkina
In the article the authors conducted a retrospective analysis of the periodization of the history of telemedicine in the Russian Federation by evaluating the data presented in scientific publications, Internet publications and monographs. In the process of writing the article the information resources of the library were used cyberleninka.ru. Тhe analysis of the existing normative-legal acts of the Russian Federation, defining the concept of “telemedicine”, the development of telemedicine in the Russian health care at the present stage and the concept of telemedicine technologies. Generalization and systematization of the revealed facts in the history of telemedicine allowed to determine the degree of development of telemedicine technologies in health care, both in Russia and abroad.

Guidelines for Authors

The requirements for submitting scientific articles are based on the 'Unified Requirements for Manuscripts Submitted to Biomedical Journals' of the International Committee of Medical Journal Editors (the official version is available on the website www.ICMJE.org).

Submission of an article implies that the work described has not been previously published or already accepted for publication in other journals. The articles are published in Belarusian, Russian, and English. The articles which do not meet the 'Rules and Norms of Humane Treatment of Biological Objects of Research' are not accepted for publication. All articles submitted to the editorial office undergo multi-stage peer review, including verification by “Anti-plagiarism” system of automatic text checking for borrowings from the publicly available information sources. Comments of reviewers are sent to the author without specifying the names of reviewers. After receiving the reviews and the author’s reply, the editorial board makes a decision on publication (or rejection) of the article. The editors reserve the right to reject the article without stating reasons. The order and sequence of an article publication is determined depending on the volume of published materials and the list of sections in a particular issue. Minor corrections of stylistic, nomenclature and formal character are made without the author’s consent. If the article was processed by the author in the process of preparation for publication, the date of receipt is considered to be the day of the final text submission.

The Editorial Board of the journal 'Emergency Cardiology and Cardiovascular Risks' accepts the following types of articles:

1) original scientific materials and research data;
2) scientific reviews.

The electronic version of the article should be typed in Microsoft Word and printed on one side of the paper, Times New Roman font, 12. The font color is black. size 14 and 1,5 spaced in two copies. The width of the left margin is 3 cm, top and bottom – 2,5 cm, right – 1 cm. Portrait orientation. No hyphenation. Formatting is made in the 'width' parameter. Headings and subheadings are typed in bold with alignment to the left; no dot is placed at the end of the heading. No other text formatting is allowed in the article. One paragraph indent is left before the headings.

1 Article Structure

1.1 Article Description (in Russian)

1.1.1 UDC (Universal Decimal Classification) code

1.1.2 Initials and surnames of the author(s)

1.1.3 Title of the article  

1.1.4 Official name of the organization where the authors work (superscript Arabic numerals indicate the institution)

1.1.5 Abstract in Russian (the volume for original research should be from 1800 to 2500 characters with spaces; and at least 1000 characters for review articles and descriptions of clinical cases). Original scientific research articles require structured abstracts: the purpose, methods, main results and conclusions of the work.

1.1.6 Keywords

1.2 Article Description (in English)

1.2.1 Initials and surnames of the author(s) (should correspond to the passport or be transliterated in the BSI system (British Standard Institute; UK, http://translit.ru/)

1.2.2 Title of the article 

1.2.3 Official name of the organization where the authors work (superscript Arabic numerals indicate the institution)

1.2.4 Abstract in English (the volume for original research should be from 1800 to 2500 characters with spaces and at least 1000 characters for review articles and descriptions of clinical cases). The abstract is a brief summary of a research article and may be published as a separate entity.

The abstract must outline the most important aspects of the study. Abstracts should have a structured format (for original scientific articles: purpose, methods, results and conclusions). However, the subject, topic, purpose, method of research are given if they are new or of special interest. The text of the abstract should be clear and concise without any secondary information, general statements or complicated grammar structures.

References to the literature and abbreviations (except standard ones) are not allowed.

The results are stated precisely. The main theoretical and experimental findings, actual data, discovered relationships and patterns are given. Special emphasis should be placed on the new findings and the data having potential practical implication.

The conclusions can be accompanied by recommendations, evaluations, suggestions, hypotheses, described in the article.

The abstract in English should not be a mere translation of the Russian version.

1.2.5 Keywords (according to MeSH).

2 Article Body

Depending on the type of the manuscript, the structure of the full text may be different.

The volume of original research and clinical cases descriptions, including figures, tables, literature index and summary should not exceed 30 thousand characters with spaces and that of reviews and lectures - 45 thousand characters with spaces.

Abbreviations are not allowed to be used, except for the chemical and common abbreviations, mathematical values, measurements and terms. The author of the article is to use the International System of Units (SI).

2.1 Original scientific articles

Original scientific articles contain the results of original research.

Sections of Original Scientific Article:

  • Introduction (not exceeding 2 pages) should state the topicality of the problem, including its significance (prevalence, morbidity, etc.) as well as mediated effects (social, economic). The solved and unsolved aspects of the problem should be identified with the analysis of previously published data.
  • Purpose of research;
  • Methods (the section should contain information on the design of the study, its duration, the method for evaluating the results, testing the hypothesis with describing the statistical methods and processing the results);
  • Results (description of the research content and main findings in detail; if necessary the section may be broken into subsections);
  • Discussion (the obtained results should be discussed from the point of view of novelty and compared with the known data);
  • Conclusion (should be presented in the form of a complete text);
  • Source of financing (specify the source of funding for the work);
  • Conflict of interests (presence of obvious and potential conflicts of interests, that is, conditions and facts that can influence the results of the research or their interpretation);
  • Expression of gratitude.

2.2 Scientific Review

The purpose of the review article should be a discussion of the accumulated material and the presentation of a new view of the author on previously described phenomena, a rethinking and search for new approaches to their interpretation, but not just listing the facts and stating the current state of the problem.

Sections of Scientific Reviews:

  • Introduction;
  • Discussion (may be presented as a separate section or run systematically through the text);
  • Conclusion (should be presented in the form of a complete text);
  • Source of financing (specify the source of funding for the analytical work);
  • Conflict of interests (presence of conflicts of interests, i.e. conditions and facts that can affect the results of the research or their interpretation);
  • Expression of gratitude.

3 References

Bibliographic index is placed at the end of the original article and should not contain more than 25 sources cited by the author. For scientific reviews it may be of no more than 50 sources in order of mention. In the text the author makes reference to the serial Index number in square brackets. Bibliographical description of the cited references should be in accordance with the requirements of the Higher Attestation Commission of the Republic of Belarus.

According to the requirements of international systems of citation the authors of the articles have to present references in the original language and in Latin alphabet. English references are identical to the ones transliterated to Latin alphabet.

4 Author information

The following elements must be included:

  • full names of all authors, their academic titles and degrees
  • postal address of the institution, the e-mail of each author and phone numbers

5 Tables

All the tables should be titled, numbered and self-explanatory. The data presented in tables should correspond to the numbers in the text but not duplicate results described elsewhere in the article. References to tables in the text are required. The titles of the tables and descriptions should be duplicated in English.

6 Illustrations

The quantity of graphics should be minimal. Each illustration should have numbered picture captions. References to illustrations are required. The titles of the figures and diagrams and their descriptions should be also duplicated in English. Links to figures in the text are required.

Illustrations (graphs, charts, drawings) performed in MS Office format should be contrast and clear. Illustrations should be performed in a separate file in*.jpeg, *.bmp, *.gif formats and placed in the article as fixed images. Do not use MS WORD to apply any elements on top of the inserted image (arrows, captions) due to the high risk of missing symbols during the editing and page make-up stages.

Photos, screenshots and other images should be embedded in the main text and also provided as separate files in *.jpeg, *.bmp, *.gif formats (*.doc and *.docx – in case of additional marks). The resolution of photographic images should be >300 dpi.

Each file should be titled and correspond to the image number in the text. In the file description picture captions should be placed and correspond to the name of the image embedded in the text.

The article should be submitted to the editor in the electronic version with the signatures of the authors. The article must be accompanied by a Letter of Application written in a free form.

Submission of an article for publication to 'Emergency Cardiology and Cardiovascular Risks' journal implies the consent of the author (s) with the published rules.

Address for letters
E-mail: emcardio@bsmu.by  

The order of reviewing article manuscripts submitted to the scientific and practical peer-reviewed journal “Emergency Cardiology and Cardiovascular Risks”

Manuscripts of all scientific articles submitted to the editors are subject to mandatory review by two independent experts. Review is carried out by the scientists who are recognized experts in the field of reviewed materials and work in the field of knowledge to which the content of the manuscript belongs and who have had publications on the subject of the article under review over the last three years.

The author, supervisor of a scientific degree scholar or coauthors of the reviewed work cannot be reviewers. The review of a scientific article is issued in accordance with the Memo to the reviewer of scientific articles and materials submitted to the journal “Emergency Cardiology and Cardiovascular Risks”.

Manuscripts are not considered for publication in case they do not meet the “Rules for Authors” which are published for convenience in the journal and its electronic version.

The editor informs the author about the review result by providing a copy of the review. The review contains recommendations for publication, correction and improvement of the article or a reasonable refusal. The author of the manuscript may take into account the recommendations when preparing a new version of the article or reasonably refute them. Articles refined by the author are resubmitted for review by a reviewer who made critical comments. The incoming date is considered to be the date of the refined article submission. If the author disagrees with the reviewer's comments, he may apply for a second review engaging a third expert or withdraw the article.

Articles and article reviews are discussed at the meeting of the editorial board, which serves as a basis to accept or reject an article. The decision of the editorial board is registered in by the protocol.

The order and priority of publications are determined depending on the volume of published materials and the list of subdivisions in a particular issue.

The editorial board does not guarantee the publication of all submitted materials. The article will not be accepted for consideration if it has been published or sent to other journals, the authors have not provided their complete personal data or the article does not meet the “Rules for Authors”. The editors reserve the right to edit the article without notifying the authors.

The final decision on the expediency of publications after their reviewing is made by the editorial board.

Articles not allowed for publication:

  • manuscripts which are not related to the scientific area of the journal;
  • manuscripts which do not meet the design requirements and their authors refuse to make their technical refinement;
  • manuscripts, the authors of which did not change the article according to the constructive requirements of the reviewer;

manuscripts, representing significant plagiarism due to copying data or conclusions from another author’s research without proper citation/reference (according to the recommendations of the World Association of Medical Editors (WAME) and COPE (Committee on Publication Ethics)); resubmission of the publication under the name of another author (in the original language or in translation); verbatim copying of more than 100 words from another (including his own) publication in the absence of a properly arranged quotation; unpublished borrowings of previously published ideas or hypotheses of other authors, and/or those that have not been tested by the “Anti-plagiarism” Automatic Text Checking System for borrowing from publicly available information sources.

If plagiarism is suspected:

the editorial board informs the experts and the author(s) of the material in writing about the initiation of the editorial investigation and its expected timeframe (2 months). Based on the results of the editorial investigation, a written statement is drawn up (stored in the editorial office), copies of which are provided to the person who discovered the fact of plagiarism and the author(s) about the decision made and the undertaken actions.

In case of insignificant plagiarism the editors of the journal must notify the author about the fact of plagiarism and obtain written explanations. If a violation by the author is qualified as unintentional, confine to a reprimand and sending a message about the inappropriateness of repeated cases. A revised manuscript with references to all original sources of borrowing may be published.

Manuscripts and electronic versions of both published and unpublished materials are not returned.

Reviews are kept in the editorial office for five years.

About Us

ISSN 2616-633X

Publishing semi-annual
Articles in Russian. Summaries in English

Address:

Dzerzhinski Ave., 83, Minsk, Republic of Belarus, 220116
Tel: +375 17 277-12-01.
Fax: +375 17 277-12-02
E-mail:  emcardio@bsmu.by
Web-site:  https://emcardio.bsmu.by

Editor-in-chief: Prof. Natalya P. Mitkovskaya, MD, PhD. Educational Institution «Belarusian State Medical University», Minsk, Belarus

Executive Secretary: Ekaterina B. Petrova, PhD Educational Institution «Belarusian State Medical University», Minsk, Belarus

Executive Editorial Office Secretary: Olga V. Laskina. Educational Institution «Belarusian State Medical University», Minsk, Belarus

 

Editor-in-chief greeting

 

Publication Ethics

Editorial Board

Sikorskij A.V., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Vojtovich T.N., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Gubkin S.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Danilova L.I., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Dzjadz`ko A.M., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Karpov I.A., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kirkovkij V.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kozlovkij V.i., Grand PhD in Medical sciences, Professor (Vitebsk, Belarus)
Kopitov A.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Ostrovskij Ju.P. A.Yu., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Petrova M.N., PhD in Philological sciences, Associate Professor  (Minsk, Belarus)
Pristrom A.M., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Rudenko E.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Rudenok V.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Ruzanov D.Yu., PhD in Medical sciences, Associate Professor (Gomel, Belarus)
Salivonchik D.P., Grand PhD in Medical sciences, Professor (Gomel, Belarus)
Sidorovich E. K., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Sudzhaeva O.A., Grand PhD in Medical sciences (Minsk, Belarus)
Uss A.L., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Tsapaeva N.L., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Yanushko A.V., PhD in Medical sciences, Associate Professor (Grodno, Belarus)

 

Advisory Editorial Board

(International Consultative Committee)

Abel`skaya I.S., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Azimferey Leonhard, Grand PhD in Medical sciences, Professor (Tîrgu Mureș, Romania)
Arutjunov G.P., Corresponding Member of the Russian Academy of Sciences , Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Bedel'baeva G.G., Grand PhD in Medical sciences, Professor (Almaty, Kazakhstan)
Beljaeva L.N., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Vismont F.I., Corresponding Member of the National Academy of Sciences o Belarus , Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Dzhunusbekova G.A., Grand PhD in Medical sciences, Professor (Almaty, Kazakhstan)
Drapkina O.M., Corresponding Member of Russian Academy of Sciences , Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Dudarenko S.V., Grand PhD in Medical sciences, Professor (St. Petersburg, Russian Federation)
Kamilova U.K., Grand PhD in Medical sciences, Professor (Tashkent, Uzbekistan)
Kibira Satoshi, Grand PhD in Medical sciences, Professor (Akita, Japan)
Koziolova N.A., Grand PhD in Medical sciences, Professor (Perm, Russian Federation)
Kostjuk William, Grand PhD in Medical sciences, Professor (London, Canada)
Krasnyj S.A., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kubarko A.I., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kul'chickij V.A., Corresponding Member of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Linn Tommi, Grand PhD in Medical sciences, Professor (Stockholm, Sweden)
Mrochek A.G., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Oganov R.G., Academician of the Russian Academy of Sciences,  Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Ostrovskij Ju.P., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Pershagen Joran, Grand PhD in Medical sciences, Professor (Stockholm, Sweden)
Pinevich D.L., First Deputy Minister of Health of the Republic of Belarus (Minsk, Belarus)
Rebrov A.P., Grand PhD in Medical sciences, Professor (Saratov, Russian Federation)
Rud Charls, Grand PhD in Medical sciences, Professor (Berkeley, USA)
Rummo O.O., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Skugarevskij O.A., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Snezhickij V.A., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Grodno, Belarus)
Sukalo A.V., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Tiffi Patrik, Grand PhD in Medical sciences, Professor (London, Canada)
Tret'jak S.I., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Fedoruk A.M., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Hirmanov V.N., Grand PhD in Medical sciences, Professor (St. Petersburg, Russian Federation)
Zhebentyayev A.I., Grand PhD in Pharmaceutical Sciences, Professor (Vitebsk, Belarus)
Gurina N.S., Grand PhD in Biological sciences, Professor (Minsk, Belarus)
Tsarenkov V.M., Grand PhD in Pharmaceutical Sciences, Professor (Minsk, Belarus)
Khishova O.M., Grand PhD in Pharmaceutical Sciences, Professor (Vitebsk, Belarus)
Kuznetsov V.A., Grand PhD in Medical sciences, Professor (Tyumen, Russian Federation)

 

Publishing Group

Antonovich Zh. V., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Balysh E. M., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Volod'ko Ju.S., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Gerasimenok D.S., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Grigorenko E.A., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Mazanik Ju.N., (Minsk, Belarus)
Martusevich N.A., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Pyko A.A., PhD in Medical sciences (Minsk, Belarus)
Rustamov M.N., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Skakun L.N., (Minsk, Belarus)
Smirnova E.S., PhD in Medical sciences (Minsk, Belarus)
Statkevich T.V., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Tenjushko E.S., (Minsk, Belarus)
Vinokurov V.F., design, computer layout (Minsk, Belarus)
Zhuk L.I., editor (Minsk, Belarus)